Literature DB >> 10930098

Growth inhibition of human glioma cells by transfection-induced P21 and its effects on telomerase activity.

K Harada1, K Kurisu, T Sadatomo, H Tahara, E Tahara, T Ide, E Tahara.   

Abstract

The aim of this study is to investigate the effect of the p21 gene transfection on the growth of cultured human glioma cell lines, and analyze the telomerase activity, and detection of telomerase components in p21 transfectant. The p21 gene was transfected into human glioma cell lines, U251MG and T98G with our novel liposome. The cell growth was assessed by counting the number of trypan blue-excluding cells in a hemocytometer and flow cytometry analysis. The expression of P21 protein and its mRNA were examined by Western and Northern blot analysis. The telomerase activity was assayed by TRAP (telomerase repeat amplification protocol)/TRAP-HPA (hybridization protection assay) method qualitatively and quantitatively. The length of telomere was measured by Southern blot analysis. The expression of telomerase components (hTERT, hTERC and TEP1) were examined by RT-PCR (reverse transcriptase-polymerase chain reaction). The p21 transfectant demonstrated the expression of P21 protein and its mRNA. The p21 transfection of human glioma cells results in growth inhibition and G0/G1 arrest. The p21 transfectant revealed a decrease of telomerase activity and hTERT expression as compared with control cells. These results suggest that p21 transfection induces G0/G1 arrest in human glioma cells which associates with the reduction in the telomerase activity and hTERT expression.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10930098     DOI: 10.1023/a:1006428529637

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  38 in total

1.  A rapid, useful and quantitative method to measure telomerase activity by hybridization protection assay connected with a telomeric repeat amplification protocol.

Authors:  M Hirose; J Abe-Hashimoto; K Ogura; H Tahara; T Ide; T Yoshimura
Journal:  J Cancer Res Clin Oncol       Date:  1997       Impact factor: 4.553

Review 2.  Molecular genetics of primary intracranial tumors.

Authors:  V P Collins; C D James
Journal:  Curr Opin Oncol       Date:  1990-08       Impact factor: 3.645

3.  Telomerase activity is associated with cell cycle deregulation in human breast cancer.

Authors:  G Landberg; N H Nielsen; P Nilsson; S O Emdin; J Cajander; G Roos
Journal:  Cancer Res       Date:  1997-02-01       Impact factor: 12.701

4.  Functional expression of human p21(WAF1/CIP1) gene in rat glioma cells suppresses tumor growth in vivo and induces radiosensitivity.

Authors:  M Hsiao; V Tse; J Carmel; E Costanzi; B Strauss; M Haas; G D Silverberg
Journal:  Biochem Biophys Res Commun       Date:  1997-04-17       Impact factor: 3.575

5.  Introduction of p21(Waf1/Cip1) gene into a carcinoma cell line of the uterine cervix with inactivated p53.

Authors:  Y Yokoyama; Y Takahashi; S Morishita; M Hashimoto; T Tamaya
Journal:  Cancer Lett       Date:  1997-06-24       Impact factor: 8.679

6.  Wild-type p53 can inhibit oncogene-mediated focus formation.

Authors:  D Eliyahu; D Michalovitz; S Eliyahu; O Pinhasi-Kimhi; M Oren
Journal:  Proc Natl Acad Sci U S A       Date:  1989-11       Impact factor: 11.205

7.  hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization.

Authors:  M Meyerson; C M Counter; E N Eaton; L W Ellisen; P Steiner; S D Caddle; L Ziaugra; R L Beijersbergen; M J Davidoff; Q Liu; S Bacchetti; D A Haber; R A Weinberg
Journal:  Cell       Date:  1997-08-22       Impact factor: 41.582

8.  Telomerase activation by hTRT in human normal fibroblasts and hepatocellular carcinomas.

Authors:  J Nakayama; H Tahara; E Tahara; M Saito; K Ito; H Nakamura; T Nakanishi; E Tahara; T Ide; F Ishikawa
Journal:  Nat Genet       Date:  1998-01       Impact factor: 38.330

9.  Telomeres shorten during ageing of human fibroblasts.

Authors:  C B Harley; A B Futcher; C W Greider
Journal:  Nature       Date:  1990-05-31       Impact factor: 49.962

Review 10.  Telomeres and telomerase in aging and cancer.

Authors:  C B Harley; B Villeponteau
Journal:  Curr Opin Genet Dev       Date:  1995-04       Impact factor: 5.578

View more
  6 in total

1.  The biological activity of G-quadruplex DNA binding papaverine-derived ligand in breast cancer cells.

Authors:  Blazej Rubis; Mariusz Kaczmarek; Natalia Szymanowska; Elzbieta Galezowska; Andrzej Czyrski; Bernard Juskowiak; Tadeusz Hermann; Maria Rybczynska
Journal:  Invest New Drugs       Date:  2008-09-05       Impact factor: 3.850

2.  Downregulation of telomerase activity by diclofenac and curcumin is associated with cell cycle arrest and induction of apoptosis in colon cancer.

Authors:  Chandan Rana; Honit Piplani; Vivek Vaish; Bimla Nehru; S N Sanyal
Journal:  Tumour Biol       Date:  2015-03-06

3.  Evidence of extra-telomeric effects of hTERT and its regulation involving a feedback loop.

Authors:  Serene R Lai; Amanda P Cunningham; Vu Q Huynh; Lucy G Andrews; Trygve O Tollefsbol
Journal:  Exp Cell Res       Date:  2006-10-25       Impact factor: 3.905

4.  Inhibitory effect of ubiquitin-proteasome pathway on proliferation of esophageal carcinoma cells.

Authors:  Wei-Guo Zhang; Jie-Ping Yu; Qing-Ming Wu; Qiang Tong; Sheng-Bao Li; Xiao-Hu Wang; Guo-Jian Xie
Journal:  World J Gastroenterol       Date:  2004-10-01       Impact factor: 5.742

5.  Dynamic telomerase gene suppression via network effects of GSK3 inhibition.

Authors:  Alan E Bilsland; Stacey Hoare; Katrina Stevenson; Jane Plumb; Natividad Gomez-Roman; Claire Cairney; Sharon Burns; Kyle Lafferty-Whyte; Jon Roffey; Tim Hammonds; W Nicol Keith
Journal:  PLoS One       Date:  2009-07-31       Impact factor: 3.240

6.  Effect of exogenous bFGF on the proliferation of human adenoid cystic carcinoma ACC-2 cells.

Authors:  Lei Ding; Shengrong Zhu; Sanxiang Xie; Xiangbing Wu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2008-05-15
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.